(Q74631100)
Statements
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model (English)
Kisker O
Becker CM
Prox D
Fannon M
D'Amato R
Flynn E
Fogler WE
Sim BK
Allred EN
Pirie-Shepherd SR